BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 19610612)

  • 1. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential protein profiling in renal-cell carcinoma.
    Shi T; Dong F; Liou LS; Duan ZH; Novick AC; DiDonato JA
    Mol Carcinog; 2004 May; 40(1):47-61. PubMed ID: 15108329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples.
    Raimondo F; Morosi L; Chinello C; Perego R; Bianchi C; Albo G; Ferrero S; Rocco F; Magni F; Pitto M
    Mol Biosyst; 2012 Apr; 8(4):1007-16. PubMed ID: 22159573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
    Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
    BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology.
    Nakamura K; Yoshikawa K; Yamada Y; Saga S; Aoki S; Taki T; Tobiume M; Shimazui T; Akaza H; Honda N
    Int J Oncol; 2006 Apr; 28(4):965-70. PubMed ID: 16525647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.
    Sun CY; Zang YC; San YX; Sun W; Zhang L
    Saudi Med J; 2010 May; 31(5):525-32. PubMed ID: 20464042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid.
    Teng PN; Hood BL; Sun M; Dhir R; Conrads TP
    J Proteome Res; 2011 Mar; 10(3):1333-42. PubMed ID: 21142074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins.
    Romaschin AD; Youssef Y; Chow TF; Siu KW; DeSouza LV; Honey RJ; Stewart R; Pace KT; Yousef GM
    Biol Chem; 2009 Feb; 390(2):125-35. PubMed ID: 19090715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panel of candidate biomarkers for renal cell carcinoma.
    Kim DS; Choi YP; Kang S; Gao MQ; Kim B; Park HR; Choi YD; Lim JB; Na HJ; Kim HK; Nam YP; Moon MH; Yun HR; Lee DH; Park WM; Cho NH
    J Proteome Res; 2010 Jul; 9(7):3710-9. PubMed ID: 20455597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma and proteomics.
    Sandim V; Pereira DA; Ornellas AA; Alves G
    Urol Int; 2010; 84(4):373-7. PubMed ID: 20224258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis.
    Sun MZ; Liu S; Tang J; Wang Z; Gong X; Sun C; Greenaway F
    Proteomics; 2009 Jun; 9(12):3285-302. PubMed ID: 19562801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE.
    Raimondo F; Salemi C; Chinello C; Fumagalli D; Morosi L; Rocco F; Ferrero S; Perego R; Bianchi C; Sarto C; Pitto M; Brambilla P; Magni F
    Mol Biosyst; 2012 Apr; 8(4):1040-51. PubMed ID: 22315040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.
    Perego RA; Bianchi C; Corizzato M; Eroini B; Torsello B; Valsecchi C; Di Fonzo A; Cordani N; Favini P; Ferrero S; Pitto M; Sarto C; Magni F; Rocco F; Mocarelli P
    J Proteome Res; 2005; 4(5):1503-10. PubMed ID: 16212400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery.
    Lin L; Huang Z; Gao Y; Yan X; Xing J; Hang W
    J Proteome Res; 2011 Mar; 10(3):1396-405. PubMed ID: 21186845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
    Stickel JS; Weinzierl AO; Hillen N; Drews O; Schuler MM; Hennenlotter J; Wernet D; Müller CA; Stenzl A; Rammensee HG; Stevanović S
    Cancer Immunol Immunother; 2009 Sep; 58(9):1407-17. PubMed ID: 19184600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
    Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
    Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.